LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | 0.6 | 173.6 | 808.9 | 200.4 | 6.4 | 1189.9 |
1 | - | - | - | - | - | - | 0.7 | 11.7 | 6.7 | 0.1 | 19.3 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 2.6 |
1 | 1.1 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 582.4 |
1 | 555.9 |
Number of post synapses: 8329
Number of pre synapses: 135
Number of output connections: 317
Coverage factor: 1.3
Columnar completeness: 0.68
Area completeness: 0.76
Cell size (columns): 80
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#MeVP17 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Pm9 (R) | GABA | 1,704 | 243.4 | 20.7% | 20.7% |
1 | MeVPMe1 (L) | Glu | 606 | 86.6 | 7.4% | 28.0% |
2 | Pm4 (R) | GABA | 477 | 68.1 | 5.8% | 33.8% |
3 | MeVC4b (L) | ACh | 411 | 58.7 | 5.0% | 38.8% |
4 | Y3 (R) | ACh | 392 | 56.0 | 4.8% | 43.5% |
5 | Pm6 (R) | GABA | 364 | 52.0 | 4.4% | 48.0% |
6 | Tm20 (R) | ACh | 332 | 47.4 | 4.0% | 52.0% |
7 | Pm10 (R) | GABA | 259 | 37.0 | 3.1% | 55.1% |
8 | C3 (R) | GABA | 258 | 36.9 | 3.1% | 58.3% |
9 | Cm34 (R) | Glu | 239 | 34.1 | 2.9% | 61.2% |
10 | TmY18 (R) | ACh | 234 | 33.4 | 2.8% | 64.0% |
11 | MeLo8 (R) | GABA | 225 | 32.1 | 2.7% | 66.7% |
12 | Pm2b (R) | GABA | 211 | 30.1 | 2.6% | 69.3% |
13 | Tm12 (R) | ACh | 177 | 25.3 | 2.1% | 71.4% |
14 | MeVPMe1 (R) | Glu | 170 | 24.3 | 2.1% | 73.5% |
15 | MeVP1 (R) | ACh | 167 | 23.9 | 2.0% | 75.5% |
16 | Tm1 (R) | ACh | 164 | 23.4 | 2.0% | 77.5% |
17 | TmY21 (R) | ACh | 108 | 15.4 | 1.3% | 78.8% |
18 | MeLo9 (R) | Glu | 107 | 15.3 | 1.3% | 80.1% |
19 | Pm8 (R) | GABA | 107 | 15.3 | 1.3% | 81.4% |
20 | Y12 (R) | Glu | 86 | 12.3 | 1.0% | 82.5% |
21 | Y13 (R) | Glu | 73 | 10.4 | 0.9% | 83.3% |
22 | Y14 (R) | Glu | 71 | 10.1 | 0.9% | 84.2% |
23 | Mi1 (R) | ACh | 69 | 9.9 | 0.8% | 85.0% |
24 | MeVC1 (L) | ACh | 64 | 9.1 | 0.8% | 85.8% |
25 | Pm2a (R) | GABA | 59 | 8.4 | 0.7% | 86.5% |
26 | TmY10 (R) | ACh | 59 | 8.4 | 0.7% | 87.3% |
27 | Y11 (R) | Glu | 47 | 6.7 | 0.6% | 87.8% |
28 | Mi10 (R) | ACh | 46 | 6.6 | 0.6% | 88.4% |
29 | TmY5a (R) | Glu | 46 | 6.6 | 0.6% | 88.9% |
30 | MeVC4a (L) | ACh | 43 | 6.1 | 0.5% | 89.5% |
31 | T2 (R) | ACh | 36 | 5.1 | 0.4% | 89.9% |
32 | Tm4 (R) | ACh | 34 | 4.9 | 0.4% | 90.3% |
33 | Tm6 (R) | ACh | 33 | 4.7 | 0.4% | 90.7% |
34 | T3 (R) | ACh | 31 | 4.4 | 0.4% | 91.1% |
35 | MeVP3 (R) | ACh | 29 | 4.1 | 0.4% | 91.4% |
36 | T2a (R) | ACh | 29 | 4.1 | 0.4% | 91.8% |
37 | TmY9b (R) | ACh | 28 | 4.0 | 0.3% | 92.1% |
38 | Tm3 (R) | ACh | 27 | 3.9 | 0.3% | 92.5% |
39 | Pm12 (R) | Glu | 23 | 3.3 | 0.3% | 92.7% |
40 | Tm5Y (R) | ACh | 23 | 3.3 | 0.3% | 93.0% |
41 | MeLo10 (R) | Glu | 22 | 3.1 | 0.3% | 93.3% |
42 | Mi4 (R) | GABA | 22 | 3.1 | 0.3% | 93.5% |
43 | TmY4 (R) | ACh | 21 | 3.0 | 0.3% | 93.8% |
44 | Ascending_TBD1 (R) | unclear | 20 | 2.9 | 0.2% | 94.0% |
45 | MeLo12 (R) | Glu | 17 | 2.4 | 0.2% | 94.3% |
46 | MeLo7 (R) | ACh | 16 | 2.3 | 0.2% | 94.4% |
47 | OA-ASM1 (R) | OA | 16 | 2.3 | 0.2% | 94.6% |
48 | OLVC5 (R) | ACh | 16 | 2.3 | 0.2% | 94.8% |
49 | Cm13 (R) | Glu | 15 | 2.1 | 0.2% | 95.0% |
50 | MeLo14 (R) | Glu | 15 | 2.1 | 0.2% | 95.2% |
51 | MeVC3 (L) | ACh | 15 | 2.1 | 0.2% | 95.4% |
52 | Cm17 (R) | GABA | 13 | 1.9 | 0.2% | 95.5% |
53 | Mi2 (R) | Glu | 13 | 1.9 | 0.2% | 95.7% |
54 | OA-ASM1 (L) | OA | 13 | 1.9 | 0.2% | 95.9% |
55 | Cm7 (R) | Glu | 12 | 1.7 | 0.1% | 96.0% |
56 | MeVP17 (R) | Glu | 12 | 1.7 | 0.1% | 96.1% |
57 | Tm40 (R) | ACh | 12 | 1.7 | 0.1% | 96.3% |
58 | MeLo11 (R) | Glu | 11 | 1.6 | 0.1% | 96.4% |
59 | OA-AL2i1 (R) | OA | 11 | 1.6 | 0.1% | 96.6% |
60 | Tm37 (R) | Glu | 11 | 1.6 | 0.1% | 96.7% |
61 | TmY14 (R) | Glu | 11 | 1.6 | 0.1% | 96.8% |
62 | TmY20 (R) | ACh | 11 | 1.6 | 0.1% | 97.0% |
63 | 5-HTPMPV03 (L) | 5HT | 10 | 1.4 | 0.1% | 97.1% |
64 | aMe17e (R) | Glu | 10 | 1.4 | 0.1% | 97.2% |
65 | Cm4 (R) | Glu | 10 | 1.4 | 0.1% | 97.3% |
66 | Tm32 (R) | Glu | 10 | 1.4 | 0.1% | 97.4% |
67 | LPT54 (R) | ACh | 9 | 1.3 | 0.1% | 97.5% |
68 | MeVC11 (L) | ACh | 9 | 1.3 | 0.1% | 97.7% |
69 | Tm31 (R) | Glu | 9 | 1.3 | 0.1% | 97.8% |
70 | Cm19 (R) | GABA | 8 | 1.1 | 0.1% | 97.9% |
71 | Tm38 (R) | ACh | 8 | 1.1 | 0.1% | 98.0% |
72 | MeVC21 (R) | Glu | 7 | 1.0 | 0.1% | 98.0% |
73 | Mi9 (R) | Glu | 7 | 1.0 | 0.1% | 98.1% |
74 | OA-AL2i2 (R) | OA | 7 | 1.0 | 0.1% | 98.2% |
75 | Tm33 (R) | ACh | 7 | 1.0 | 0.1% | 98.3% |
instance | NT | total connections | connections /#MeVP17 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeLo9 (R) | Glu | 36 | 5.1 | 10.1% | 10.1% |
1 | Pm4 (R) | GABA | 34 | 4.9 | 9.6% | 19.7% |
2 | MeLo8 (R) | GABA | 23 | 3.3 | 6.5% | 26.1% |
3 | T2 (R) | ACh | 19 | 2.7 | 5.3% | 31.5% |
4 | Tm6 (R) | ACh | 19 | 2.7 | 5.3% | 36.8% |
5 | TmY5a (R) | Glu | 19 | 2.7 | 5.3% | 42.1% |
6 | Pm9 (R) | GABA | 18 | 2.6 | 5.1% | 47.2% |
7 | Tm1 (R) | ACh | 14 | 2.0 | 3.9% | 51.1% |
8 | MeVP17 (R) | Glu | 12 | 1.7 | 3.4% | 54.5% |
9 | TmY21 (R) | ACh | 12 | 1.7 | 3.4% | 57.9% |
10 | MeVP3 (R) | ACh | 11 | 1.6 | 3.1% | 61.0% |
11 | TmY18 (R) | ACh | 11 | 1.6 | 3.1% | 64.0% |
12 | Y3 (R) | ACh | 11 | 1.6 | 3.1% | 67.1% |
13 | T2a (R) | ACh | 8 | 1.1 | 2.2% | 69.4% |
14 | T3 (R) | ACh | 8 | 1.1 | 2.2% | 71.6% |
15 | MeVP18 (R) | unclear | 7 | 1.0 | 2.0% | 73.6% |